Chondroitin sulfate (CS) is a sulfated glycosaminoglycan widely distributed in cartilage and other connective tissues, where it contributes to matrix structure and biomechanical properties. It is also used pharmacologically and as a biomaterial component in joint disease and regenerative medicine.
Chemical structure
Chondroitin sulfate is a linear, unbranched polysaccharide composed of repeating disaccharide units of D‑glucuronic acid and N‑acetyl‑D‑galactosamine linked via alternating β(1→4) and β(1→3) glycosidic bonds. Sulfation occurs mainly at the 4‑ and/or 6‑hydroxyl groups of N‑acetyl‑D‑galactosamine, and less frequently at positions on glucuronic acid, generating structurally distinct isoforms (e.g. CS‑A, CS‑C, CS‑D, CS‑E).
Physicochemical properties
CS carries a high density of negative charges due to carboxylate and sulfate groups, leading to strong hydration and the ability to form highly viscous aqueous solutions at relatively low concentrations. These anionic groups mediate electrostatic interactions with mono‑ and divalent cations (Na⁺, K⁺, Ca²⁺, Mg²⁺, etc.) and with cationic biomolecules, enabling formation of polysaccharide–metal complexes and conjugates.
Biosynthesis and distribution
Endogenously, CS is synthesized in the Golgi apparatus as part of proteoglycans, where the polysaccharide chains are attached to serine residues of core proteins such as aggrecan and versican via a tetrasaccharide linker on the protein backbone. It is abundant in articular cartilage, intervertebral discs, blood vessels, skin, and the central nervous system, where it contributes to extracellular matrix architecture and osmotic swelling pressure.
Biological functions
In cartilage, CS-containing proteoglycans generate a fixed negative charge that attracts water and counterions, providing compressive resistance and elasticity essential for joint function. CS also modulates cell adhesion, proliferation, and neurite outgrowth through sulfation‑pattern‑dependent interactions with growth factors, chemokines, and cell-surface receptors, giving it roles in development, plasticity, and tissue repair or inhibition thereof (e.g. glial scar).
Pharmacological and clinical applications
Oral chondroitin sulfate is used as a symptomatic slow‑acting drug in osteoarthritis, often combined with glucosamine, where clinical studies report modest improvements in pain and function in subsets of patients, though results remain heterogeneous. Injectable or formulated CS has been explored in ophthalmic preparations, wound dressings, and as a component of biomaterials for cartilage and bone regeneration due to its biocompatibility and matrix‑mimetic properties.
